Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/CHEBI_68584
http://purl.obolibrary.org/obo/CHEBI_68584
|
|---|---|
| Preferred Name | ezogabine |
| Synonyms |
Ethyl 2-amino-4-((p-fluorobenzyl)amino)carbanilate
N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester
N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester
D-23129
ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate
ethyl N-(2-amino-4-{[(4-fluorophenyl)methyl]amino}phenyl)carbamate
retigabine
Potiga
C16H18FN3O2
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | ezogabine
|
|---|---|
| label | ezogabine
|
| DBSynonym |
d23129
d-23129
retigabine
ezg
rtg
|
| ATCCode | N03AX21
|
| Definition | Ezogabine (D23129) is a close structural analog of the centrally acting analgesic flupitrine. It is a neuronal potassium channel opener being developed as a first-in-class antiepileptic drug (AED) and is currently being studied in Phase 3 trials as an adjunctive treatment for partial-onset seizures in adult patients with refractory epilepsy. FDA approved in June 10, 2011 under the name of ezogabine.
A substituted aniline that is benzene-1,2,4-triamine bearing ethoxycarbonyl and 4-fluorobenzyl substituents at positions N-1 and N-4 respectively. An anticonvulsant used to treat seizures associated with epilepsy in adults.
|
| inhibits | |
| type | |
| has role | |
| InChIKey | InChIKey=PCOBBVZJEWWZFR-UHFFFAOYSA-N
|
| is metabolised by | |
| AHFScode | 28:12.92
|
| Synonym |
Ethyl 2-amino-4-((p-fluorobenzyl)amino)carbanilate
N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester
N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester
D-23129
ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate
ethyl N-(2-amino-4-{[(4-fluorophenyl)methyl]amino}phenyl)carbamate
retigabine
Potiga
C16H18FN3O2
See more
See less
|
| xref |
PubChem Compound:121892
Patent:US2012053238
Reaxys:8072099
KEGG DRUG:D09569
Wikipedia:http://en.wikipedia.org/wiki/Retigabine
CiteXplore:22991134
Patent:US6348486
Drugs.com:http://www.drugs.com/mtm/ezogabine.html
CASRN:150812-12-7
PharmGKB:PA144997862
PubChem Substance:10239851
ChEMBL:161945
Patent:US5384330
Patent:WO2007090409
ChEBI:68584
BindingDB:50143558
Patent:US2002111379
Patent:US2002015730
Patent:WO2011012659
ChemSpider:108740
RxList:http://www.rxlist.com/potiga-drug.htm
KEGG COMPOUND:C13826
National Drug Code Directory:0173-0814-59
Patent:US2002183395
Wikipedia:Ezogabine
See more
See less
|
| CASRN | 150812-12-7
|
| prefixIRI | obo2:CHEBI_68584
|
| related with | |
| SMILES |
CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N
CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1
|
| may interact with | |
| InChI | InChI=1S/C16H18FN3O2/c1-2-22-16(21)20-15-8-7-13(9-14(15)18)19-10-11-3-5-12(17)6-4-11/h3-9,19H,2,10,18H2,1H3,(H,20,21)
|
| DBBrand | potiga
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |